Acumen Pharmaceuticals, Inc.

ABOSNASDAQHealthcare● Active

$2.17

+$0.02(+0.93%)

Market Cap$131444278

P/E Ratio—

52W High$3.6

52W Low$1.05

Avg Volume537K

Open$2.17

Beta0.35

Cash on Hand Financials Revenue

Acumen Pharmaceuticals, Inc. (ABOS) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

ABOS · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$116.9M▼ -31.9% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$54.0M

cashAndCashEquivalents

Short-Term Investments

$62.9M

shortTermInvestments

YoY Change vs Prior Year

-31.9%

vs prior fiscal year

Latest Quarter

$128.4M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$116.9MCash on Hand

Total Debt$31.3MTotal Debt

Net Cash / Net Debt+$85.6MNet Cash Position

Cash vs Debt Ratio

Cash 79%Acumen Pharmaceuticals, Inc. cash as % of market cap: 88.91%% · MCap $0BDebt 21%

Acumen Pharmaceuticals, Inc. has a net cash position of $85.6M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$116.9M − $31.3M = +$85.6M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

ABOS annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

ABOS cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$116.9M-31.9%

Dec 31, 2024FY$171.6M-29.6%

Dec 31, 2023FY$243.5M+37.1%

Dec 31, 2022FY$177.6M-8.6%

Dec 31, 2021FY$194.2M+343.7%

ABOS cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

ABOS vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Acumen Pharmaceuticals, Inc.YOU

ABOS

$116.9M$131M88.9%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Acumen Pharmaceuticals, Inc. (ABOS) cash on hand as of December 31, 2025 is $116.9M, comprising $54.0M in cash and cash equivalents (CCE) plus $62.9M in short-term investments — reported as Acumen Pharmaceuticals, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Acumen Pharmaceuticals, Inc. cash reserves or cash position.

Acumen Pharmaceuticals, Inc. annual cash on hand history shows decreased -31.9% in 2025: decreased -31.9% in 2025. Acumen Pharmaceuticals, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Acumen Pharmaceuticals, Inc. carries total debt of $31.3M against cash of $116.9M, resulting in a net cash position of +$85.6M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

ABOS cash on hand · 5 questions

As of December 31, 2025, Acumen Pharmaceuticals, Inc. (ABOS) has $116,865,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $53,989,000 in cash and cash equivalents (CCE) plus $62,876,000 in short-term investments. Latest quarter (March 31, 2026): $128,398,000. Data sourced from the annual 10-K filing via FMP.

ABOS cash on handABOS cash reservesABOS cash 2025how much cash does ABOS have

▸ Source: FMP /balance-sheet-statement · US GAAP · Acumen Pharmaceuticals, Inc. · Acumen Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025